ArticleOncoTargets and therapy2019

Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.

Yanpeng Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.